help_outline Skip to main content


Things looking a little different since your last visit? Don't worry - it's us, not you!

We are currently in the process of updating this website to better improve
your experience, but you should still be able to access all the information as usual. 

Thank you for your patience and we look forward to launching the new design for you!

Shopping Cart
cancel

News / Articles

Adjuvant Melatonin for the Prevention of Recurrence and Mortality Following Lung Cancer Resection

Dugald Seely et al.  | Published on 4/7/2021
Despite curative intent resection in patients with non-small cell lung cancer (NSCLC), recurrence leading to mortality remains too common. Melatonin has shown promise for the treatment of patients with lung cancer; however, its effect following cancer resection has not been studied. We evaluated if melatonin taken after complete resection reduces lung cancer recurrence and mortality, or impacts quality of life (QOL), symptomatology or immune function. Read more here.

All News / Articles